Minimizing the invasiveness of traditional trabeculectomy surgery

Abstract

Microinvasive invasive glaucoma surgery has become increasingly popular as a surgical alternative for glaucoma. Although the time-honored trabeculectomy remains the unrivaled contender for lowering intraocular pressure (IOP) into the single digits, newer devices are available that attempt to reach similar IOP levels with fewer complications and quicker visual recovery. The Express mini-shunt and the Innfocus microshunt are 2 devices that bring us closer to the goal of repeatable, lower risk surgery; improved patient satisfaction; stabilization of the visual field; and long-term IOP control. The mini-shunt has been approved by the U.S. Food and Drug Administration, while the microshunt is still under review.

Financial disclosures: Dr. Condon is a consultant to and speaker for Alcon Laboratories. Dr. Moster has served on the advisory board of, been a consultant to, received honoraria for lectures from, and performed contracted research for Alcon, Inc.